Burning, itching, redness, or a lump after an injection should be described to the prescribing team rather than assumed to be a normal sign that sermorelin is working. The cause can depend on the product, supplies, technique, and the person's response. Appearance alone cannot reliably distinguish irritation, allergy, or infection.
If you have trouble breathing, swelling of the tongue or throat, fainting, or a rapidly developing serious reaction, seek emergency help immediately. For a local change without those symptoms, ask the clinician or pharmacist how promptly it should be assessed and what to do before the next dose.
A local reaction is not proof that treatment is working. Worsening skin changes or symptoms beyond the injection site need appropriate medical assessment.
Start with what happened and when
Record when the injection was given, when the skin change appeared, whether it is spreading, and whether pain or itching is improving or worsening. Note fever, chills, or symptoms elsewhere. If the team requests a photograph, use clear lighting and provide the date and time.
Give the complete product name and the dispensing pharmacy. If the vial is a blend, say so. The Mayo Clinic sermorelin reference is a medicine reference, but it cannot identify what happened with your actual compounded preparation. The label and clinical assessment are essential context.
Rapidly worsening skin symptoms need attention
The CDC describes cellulitis as a bacterial skin infection that can cause warmth, redness, pain, and swelling. It advises immediate medical attention for rapidly spreading redness or fever or chills. These features warrant assessment; they do not mean that every red injection site is infected.
Do not wait for a predetermined number of days from a forum post if the area is worsening or you feel unwell. A remote description may not be enough to decide what treatment is needed. Ask whether an in-person examination is appropriate.
Allergy can involve more than the skin
MedlinePlus explains that anaphylaxis can develop quickly and affect breathing, circulation, the mouth or throat, and other body systems. Call 911 for a serious allergic reaction. If you have been prescribed an epinephrine auto-injector, follow your emergency plan while obtaining help.
A previous injection without difficulty does not allow an online article to clear a new reaction. Do not take another dose to see whether the same symptoms happen again. Ask the treating professional to determine whether and how the prescription should continue.
Have the pharmacy review the actual supplies and instructions
For a nonemergency concern, ask the pharmacist to review the prescribed route, supplied syringe and needle, preparation instructions, and storage history. Describe any change in product, concentration, or supplies at the most recent refill. Our injection guide can help prepare those questions.
Do not independently change the route, dilute the vial, add another liquid, or reuse a needle to experiment with the reaction. If preparation is required, the reconstitution guide explains why instructions must refer to the exact prescription.
A normal-looking vial does not settle a quality concern
The FDA's compounding-risk guidance describes contamination and incorrect-strength concerns. A clear solution does not prove that a product is sterile, just as a skin reaction does not by itself prove contamination.
Keep the label and lot or batch information available, and contact the pharmacy about damaged packaging, unexpected particles, a temperature excursion, or a reaction that starts with a new supply. Use the storage guide for the information that helps the dispensing team assess handling questions.
Ask for a clear next-step plan
Before another injection, establish whether the product should be held pending assessment, whether the skin needs examination, and who will review the concern. Request instructions in writing if there is any ambiguity. Do not cover up worsening symptoms simply to finish a prepaid supply.
The side-effects overview provides broader context for reporting symptoms. A useful response should address both the immediate reaction and the reason for continuing the medicine, with enough detail that you do not have to guess at home.
Sources & further reading
Provider pages describe offers; they do not independently establish treatment benefits. Sources checked September 20, 2026.
This article is education, not a diagnosis, prescription, or dosing plan. Discuss treatment and alternatives with a licensed clinician who knows your history. Compounded medications are not FDA-approved.